Based on the study of gene expression levels in samples from IBD patients (inflammatory and non-inflammatory mucosa) and non-IBD patients (non-inflammatory mucosa), GSDMB was suggested to contribute to IBD susceptibility (Söderman et al., 2015). Here, GSDMB is linked to inflammatory bowel disease.